Skip to main content
logo
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
67.70
-1.25 (-1.81%)
Dec 30, 2025, 4:00 PM EST - Market closed

Halozyme Therapeutics Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Royalties
780.29M699.31M618.59M570.99M522.62M482.00M468.82M447.87M
Royalties Growth
49.30%45.09%31.95%27.49%21.04%15.61%20.05%24.24%
Product Sales
333.14M325.57M322.95M303.49M303.73M303.64M298.64M300.85M
Product Sales Growth
9.68%7.22%8.14%0.88%7.55%18.02%30.02%57.49%
Revenues Under Collaborative Agreements
129.42M153.79M142.77M140.84M121.00M87.67M95.53M80.53M
Revenues Under Collaborative Agreements Growth
6.96%75.42%49.45%74.88%81.95%-11.86%12.67%-25.85%

Operating Expense Breakdown

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Cost of Sales
192.06M186.24M179.49M159.42M169.66M175.06M185.52M192.36M
Cost of Sales Growth
13.20%6.39%-3.25%-17.13%-6.87%0.22%17.01%38.09%
Selling, General, and Administrative
172.31M167.47M161.56M154.34M149.69M143.72M146.96M149.18M
Selling, General, and Administrative Growth
15.11%16.52%9.94%3.45%0.25%-3.23%-12.03%3.94%
Amortization
71.05M71.05M71.05M71.05M71.05M73.63M73.70M73.77M-----------------
Amortization Growth
-0.00%-3.50%-3.60%-3.69%17.31%9.22%20.85%------------------
Research and Development
70.03M71.24M74.74M79.05M79.94M78.81M77.50M76.36M
Research and Development Growth
-12.40%-9.60%-3.56%3.52%3.03%2.38%6.55%14.65%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.